Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELUMETINIB vs SERPLULIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELUMETINIB vs SERPLULIMAB: Safety Overview

Metric SELUMETINIB SERPLULIMAB
Total FAERS Reports 1,172 137
Deaths Reported 81 36
Death Rate 6.9% 26.3%
Hospitalizations 211 81
Average Patient Age 25.6 yrs 63.0 yrs
% Female Patients 51.6% 11.1%
FDA Approval Date Apr 10, 2020 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Prescription N/A